Restorative Therapies, Inc., a designer of medical devices providing clinic and in-home restoration therapy, today announced FDA clearance of Functional Electrical Stimulation (FES) Arm Cycling as part of its successful medical device, the RT300, an FES motorized cycle ergometer.

Baltimore, MD (PRWEB) November 29, 2007 -- Restorative Therapies, Inc., advances its new era in treatment for neurological injury and paralysis as this FDA clearance marks the world's first commercial release of Functional Electrical Stimulation (FES) for Arm Cycling.

In the treatment of neurological damage, FES is used to evoke physical activity and exercise not otherwise possible for individuals with a neurological impairment. This latest RT300 capability delivers electrical currents to stimulate nerves which activate arm muscles including the biceps, triceps, supraspinatus, anterior and posterior deltoids and the muscles of the forearm. This enables a patient's paralyzed or weak arms to move through patterned physical activity utilizing their own muscles.

"FES Arm Cycling is a true world first. Physical Therapists and now Occupational Therapists are able to provide the RT300's activity based therapy not only to impaired legs but also to impaired arms." says John McDonald, MD, PhD, founder of Restorative Therapies, Inc., lead Neurologist to the Late Christopher Reeve, and director of the International Center for Spinal Cord Injury at the Kennedy Krieger Institute in Baltimore.

"Often after a stroke, only one side of the body is impaired; after a spinal cord injury commonly both sides are involved. FES Arm Cycling can be used to stimulate muscle groups in just one impaired arm or in both, customized to the needs of the individual." McDonald concludes.

"This new FES for Arms capability utilizes all of the great RT300 features including dynamic motor support, internet connectivity, self advancing smart therapy and wheel up ease of use." says Andrew Barriskill, CEO of Restorative Therapies. "We are excited to introduce this world first therapy to a large group of patients who currently have no other physical activity options for their arms."

FES for Arm Cycling is the latest result of Restorative Therapies commitment to ongoing development of the RT300 system; it is the third FDA clearance for the RT300 system during 2007.

About Restorative Therapies, Inc.
Restorative Therapies is a privately-held company headquartered in Baltimore, Md., whose mission is to help people with neurological impairment achieve their full recovery potential. Restorative Therapies is one of the first companies to target activity-based therapy and FES as a treatment for immobility associated with paralysis such as stroke, multiple sclerosis and spinal cord injury.

For further information please call 800 609-9166 option 1

###

Simillar Articles

FDA Clears Unilateral Stimulation for the RT300 Functional Electrical Stimulation (FES) Motorized...

Restorative Therapies, Inc., today announced FDA clearance of Unilateral Stimulation for its successful medical device, the RT300, a Functional electrical stimulation (FES) motorized cycle...

Restorative Therapies, Inc., Receives FDA Clearance for Enhancement to RT300-S Electrical...

Restorative Therapies, Inc., a designer of medical devices providing clinic and in-home resoration therapy, today announced FDA clearance of wireless pulse oximetry for its successful medical...

Stroke Rehabilitation System Biomove 5000 Approved by the US FDA

The US FDA approves marketing of the most advanced Stroke Rehabilitation system in the world, manufactured by the Israeli company Curatronic Ltd.

The American Occupational Therapy Association (AOTA) Endorses the NESS H200(R) Hand...

Bioness Inc. announced today that the NESS H200 Hand Rehabilitation System received the official endorsement of the American Occupational Therapy Association (AOTA).

New Clinical Evidence Shows Treatment Breakthrough for Foot Drop in Chronic Stroke and Traumatic...

Bioness Inc. announced that research findings presented today at the American Stroke Association's International Stroke Conference 2008 in New Orleans, LA showed that extended use of the NESS...

Home